CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...